Host anti-microbial response to Helicobacter pylori infection

Molecular Immunology

Volumn 40, Issue 7, 2003, Pages 451-456

  George, John T ^a   Boughan, Parjeet K ^a   Karageorgiou, Haris ^b   Bajaj Elliott, Mona ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anti bacterial peptides; Helicobacter pylori; Human defensins; Innate immunity

Indexed keywords

BETA DEFENSIN;

ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; DRUG POTENCY; DRUG POTENTIATION; EPITHELIUM CELL; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; STOMACH EPITHELIUM;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 0141987887     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00158-5     Document Type: Article

References (29)

1. Bajaj-Elliott M., Fedeli P., Smith G.V., Domizio P., Maher L., Ali R.S., Quinn A.G., Farthing M.J. Modulation of host anti-microbial peptide (β-defensins 1 and 2) expression during gastritis. Gut. 51:2002;356-361.
2. Bamford K.B., Fan X., Crowe S.E., Leary J.F., Gourley W.K., Luthra G.K., Brooks E.G., Graham D.Y., Reyes V.E., Ernst P.B. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 114:1998;482-492.
3. Bevins C.L., Martin-Porter E., Ganz T. Defensins and innate host defence of the gastrointestinal tract. Gut. 45:1999;911-915.
4. Blanchard T.G., Czim S.J., Redline R.W., Sigmund N., Harriman G., Nedrud J.G. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell. Immunol. 191:1999;74-80.
5. Boman H.G. Peptide antibiotics and their role in innate immunity. Ann. Rev. Immunol. 13:1995;61-92.
6. Cover T.L., Blaser M.J. Helicobacter pylori and gastroduodenal disease. Annu. Rev. Med. 43:1992;135-145.
7. Crabtree J.E. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment. Pharmacol. Therp. Suppl. 1:1996;29-37.
8. Diamond G., Zasloff M., Eck H., Brasseur M., Maloy W.L., Bevins C.L. Tracheal anti-microbial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. U.S.A. 188:1991;3952-3956.
9. Farthing M.J. Helicobacter pylori infection: an overview. Br. Med. Bull. 54:1998;1-6.
10. Ganz T. Defensins and host defense. Science. 286:1999;420-421.
11. Garcia J.R., Jaumann F., Schulz S., Krause A., Rodriguez-Jimenez J., Forssmann U., Adermann K., Kluver E., Vogelmeier C., Becker D., Hedrich R., Forssmann W.G., Bals R. Identification of a novel, multifunctional β-defensin (human β-defensin-3) with specific anti-microbial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306:2001;257-264.
12. Garcia J.R., Krause A., Schulz S., Rodriguez-Jimenez F.J., Kluver E., Adermann K., Forssmann U., Frimpong-Boateng A., Bals R., Forssmann W.G. Human β-defensin. Part 4. A novel inducible peptide with a specific salt-sensitive spectrum of anti-microbial activity. FASEB J. 10:2001;1819-1821.
13. Hamanaka Y., Nakashima M., Wada A., Ito M., Kurazono H., Hojo H., Nakahara Y., Kohno S., Hirayama T., Sekine I. Expression of human β-defensin-2 (hBD-2) in Helicobacter pylori induced gastritis: anti-bacterial effect of hBD-2 against Helicobacter pylori. Gut. 49:2001;481-487.
14. Harder J., Bartels J., Christophers E., Schroder J.M. A peptide antibiotic from human skin. Nature. 388:1997;416.
15. Harder J., Meyer-Hoffert U., Teran L.M., Schwichtenberg L., Bartels J., Maune S., Schroder J.M. Mucoid Pseudomonas aeruginosa, TNF-α, and IL-1β, but not IL-6, induce human β-defensin-2 in respiratory epithelia. Am. J. Respir. Cell. Mol. Biol. 22:2000;714-721.
16. Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:2001;5707-5713.
17. Karttunen R., Karttunen T., Ekre H.P., MacDonald T.T. Interferon-γ and interleukin-4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut. 36:1995;341-345.
18. Krisanaprakornkit S., Kimball J.R., Dale B.A. Regulation of human β-defensin-2 in gingival epithelial cells: the involvement of mitogen-activated protein kinase pathways, but not the NF-κB transcription factor family. J. Immunol. 168:2002;316-324.
19. O'Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., Kagnoff M.F. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163:1999;6718-6724.
20. O'Neil D.A., Cole S.P., Martin-Porter E., Housley M.P., Liu L., Ganz T., Kagnoff M.F. Regulation of human β-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect. Immun. 68:2000;5412-5415.
21. Parsonnet J., Hansen S., Rodriguez L., Gelb A.B., Warnke R.A., Jellum E., Orentreich N., Vogelman J.H., Friedman G.D. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1994;1267-1271.
22. Schibli D.J., Hunter H.N., Aseyev V., Starner T.D., Wiencek J.M., McCray P.B. Jr., Tack B.F., Vogel H.J. The solution structures of the human β-defensins lead to a better understanding of the potent bactericidal activity of hBD3 against Staphylococcus aureus. J. Biol. Chem. 277:2002;8279-8289.
23. Uehara N., Yagihashi A., Kondoh K., Tsuji N., Fujita T., Hamada H., Watanabe N. Human β-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: anti-microbial effect of overexpression. J. Med. Microbiol. 52(Part 1):2003;41-45.
24. Valore E.V., Park C.H., Quayle A.J., Wiles K.R., McCray P.B. Jr., Ganz T. Human β-defensin-1: an anti-microbial peptide of urogenital tissues. J. Clin. Invest. 101:1998;1633-1642.
25. Wada A., Mori N., Oishi K., Hojo H., Nakahara Y., Hamanaka Y., Nagashima M., Sekine I., Ogushi K., Niidome T., Nagatake T., Moss J., Hirayama T. Induction of human β-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. Biochem. Biophys. Res. Commun. 263:1999;770-774.
26. Yamaguchi Y., Nagase T., Makita R., Fukuhara S., Tomita T., Tominaga T., Kurihara H., Ouchi Y. Identification of multiple novel epididymis-specific β-defensin isoforms in humans and mice. J. Immunol. 169(5):2002;2516-2523.
27. Zasloff M. Anti-microbial peptides of multicellular organisms. Nature. 415:2002;389-395.
28. Zhang Q.B., Etolhi G., Dawodu J.B., Gemmell C.G., Russell R.I. Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation. Clin. Sci. 96:1999;409-414.
29. Zhao C., Wang I., Lehrer R.I. Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396:1996;319-322.